Bevacizumab, Vandetanib, Cabozantinib, Ramucirumab, Tivozanib, Ponatinib, Axitinib, Lenvatinib, Sorafenib, Nintedanib, Regorafenib, Sunitinib, Pazopanib, Aflibercept [JUL 2020]